SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-052993
Filing Date
2023-04-28
Accepted
2023-04-28 16:17:23
Documents
4
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231964d1_def14a.htm DEF 14A 590903
2 GRAPHIC tm231964d1_def14aimg001.jpg GRAPHIC 10429
3 GRAPHIC tm231964d1_def14aimg002.jpg GRAPHIC 397289
4 GRAPHIC tm231964d1_def14aimg003.jpg GRAPHIC 143345
  Complete submission text file 0001104659-23-052993.txt   1351336
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38899 | Film No.: 23866507
SIC: 2834 Pharmaceutical Preparations